Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLO-ASC-DFU in diabetic Wagner grade 2 foot ulcers
NCT04569409Phase 3Completed
- Sponsor
- Anterogen Co., Ltd.
- Start
- Jul 2020
- Primary completion
- Dec 2024
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 3 trial of allo-asc in diabetic foot ulcer (DFU), sponsored by Anterogen Co., Ltd.. Started Jul 2020; status: completed.
02
Drugs
allo-asc
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT04569409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04569409.